Platinum Investment Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Platinum Investment Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-103,858	Closed	-$3.46M	–	139
2024 Q3	$3.46M	Sell	103,858 -10,189	-9%	-$351K	0.16%	53
2024 Q2	$3.08M	Sell	114,047 -13,001	-10%	-$256K	0.12%	52
2024 Q1	$2.74M	Hold	127,048	–	–	0.11%	62
2023 Q4	$766K	Buy	+127,048	New	+$633K	0.03%	95

Platinum Investment Management's LBPH Position: Q4 2024 in Review

Platinum Investment Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 103,858 shares — an estimated $3.46M sold.

Platinum Investment Management first reported a position in LBPH in Q4 2023 and held it in 4 quarters. The position peaked at $3.46M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Platinum Investment Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Platinum Investment Management sold 103,858 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $3.46M.
Platinum Investment Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 4 quarters.
Platinum Investment Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $3.46M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Platinum Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.